• 1
    Acalovschi M, Pascu M, Iobagiu S, Petrescu M, Olinici CD, Ban A, et al. Increasing gallstone prevalence and cholecystectomy rate in a large Romanian town. A necropsy study. Dig Dis Sci 1995; 40: 2582-2586.
  • 2
    Lammert F, Sauerbruch T. Mechanisms of disease: the genetic epidemiology of gallbladder stones. Nat Clin Pract Gastroenterol Hepatol 2005; 2: 423-433.
  • 3
    Everhart JE, Yeh F, Lee ET, Hill MC, Fabsitz R, Howard BV, et al. Prevalence of gallbladder disease in American Indian populations: findings from the Strong Heart Study. Hepatology 2002; 35: 1507-1512.
  • 4
    Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet 2006; 368: 230-239.
  • 5
    Liver Diseases Subcommittee of the Digestive Diseases Interagency Coordinating Committee. Gallbladder and biliary disease. In: National Institutes of Health, ed. Action Plan for Liver Disease Research. Bethesda, MD: National Institutes of Health; 2004: 144-150.
  • 6
    Lazaridis KN. Genetics and genomics of complex diseases in hepatology. Semin Liver Dis 2007; 27: 1-2.
  • 7
    Carey MC, Paigen B. Epidemiology of the American Indians' burden and its likely genetic origins. HEPATOLOGY 2002; 36: 781-791.
  • 8
    Wittenburg H, Lammert F. Genetic predisposition to gallbladder stones. Semin Liver Dis 2007; 27: 109-121.
  • 9
    Miquel JF, Covarrubias C, Villaroel L, Mingrone G, Greco AV, Puglielli L, et al. Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Amerindians, and Maoris. Gastroenterology 1998; 115: 937-946.
  • 10
    Katsika D, Grjibovski A, Einarsson C, Lammert F, Lichtenstein P, Marschall HU. Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs. HEPATOLOGY 2005; 41: 1138-1143.
  • 11
    Nakeeb A, Comuzzie AG, Martin L, Sonnenberg GE, Swartz-Basile D, Kissebah AH, et al. Gallstones: genetics versus environment. Ann Surg 2002; 235: 842-849.
  • 12
    Rosmorduc O, Hermelin B, Boelle PY, Parc R, Taboury J, Poupon R. ABCB4 gene mutation-associated cholelithiasis in adults. Gastroenterology 2003; 125: 452-459.
  • 13
    Van Mil SW, van der Woerd WL, van der Brugge G, Sturm E, Jansen PL, Bull LN, van den Berg IE, et al. Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11. Gastroenterology 2004; 127: 379-384.
  • 14
    Lammert F, Carey MC, Paigen B. Chromosomal organization of candidate genes involved in cholesterol gallstone formation: a murine gallstone map. Gastroenterology 2001; 120: 221-238.
  • 15
    Lyons MA, Wittenburg H. Cholesterol gallstone susceptibility loci: a mouse map, candidate gene evaluation, and guide to human LITH genes. Gastroenterology 2006; 131: 1943-1970.
  • 16
    Wittenburg H, Lyons MA, Li R, Churchill GA, Carey MC, Paigen B. FXR and ABCG5/ABCG8 as determinants of cholesterol gallstone formation from quantitative trait locus mapping in mice. Gastroenterology 2003; 125: 868-881.
  • 17
    Berge KE, Tian H, Graf GA, Yu L, Grishin NV, Schultz J, et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 2000; 290: 1771-1775.
  • 18
    Carey MC, Lamont JT. Cholesterol gallstone formation. 1. Physical-chemistry of bile and biliary lipid secretion. Prog Liver Dis 1992; 10: 139-163.
  • 19
    Kern F. Effects of dietary cholesterol on cholesterol and bile acid homeostasis in patients with cholesterol gallstones. J Clin Invest 1994; 93: 1186-1194.
  • 20
    Wang DQ. Regulation of intestinal cholesterol absorption. Annu Rev Physiol 2007; 69: 221-248.
  • 21
    Lee MH, Lu K, Hazard S, Yu H, Shulenin S, Hidaka H, et al. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet 2001; 27: 79-83.
  • 22
    Berge KE, von Bergmann K, Lütjohann D, Guerra R, Grundy SM, Hobbs HH, et al. Heritability of plasma noncholesterol sterols and relationship to DNA sequence polymorphism in ABCG5 and ABCG8. J Lipid Res 2002; 43: 486-494.
  • 23
    Gylling H, Hallikainen M, Pihlajamaki J, Agren J, Laakso M, Rajaratnam RA, et al. Polymorphisms in the ABCG5 and ABCG8 genes associate with cholesterol absorption and insulin sensitivity. J Lipid Res 2004; 45: 1660-1665.
  • 24
    Plat J, Bragt MC, Mensink RP. Common sequence variations in ABCG8 are related to plant sterol metabolism in healthy volunteers. J Lipid Res 2005; 46: 68-75.
  • 25
    Acalovschi M, Ciocan A, Mosteanu O, Tirziu S, Chiorean E, Keppeler H, et al. Are plasma lipid levels related to ABCG5/ABCG8 polymorphisms? A preliminary study in siblings with gallstones. Eur J Intern Med 2006; 17: 490-494.
  • 26
    Hauser ER, Haines J, Goldgar DE. Nonparametric linkage analysis. In: HainesJL, Pericak-VanesM, eds. Genetic Analysis of Complex Diseases. 2nd ed. Hoboken, NJ: John Wiley & Sons; 2006. :283-328.
  • 27
    Grimes DA, Schulz KF. Compared to what? Finding controls for case-control studies. Lancet 2005; 365: 1429-1433.
  • 28
    Kajinami K, Brousseau ME, Nartsupha C, Ordovas JM, Schaefer EJ. ATP binding cassette transporter G5 and G8 genotypes and plasma lipoprotein levels before and after treatment with atorvastatin. J Lipid Res 2004; 45: 653-656.
  • 29
    Hubacek JA, Berge KE, Stefkova J, Pitha J, Skodova Z, Lanska V, et al. Polymorphisms in ABCG5 and ABCG8 transporters and plasma cholesterol levels. Physiol Res 2004; 53: 395-401.
  • 30
    Hill WG, Weir BS. Maximum-likelihood estimation of gene location by linkage disequilibrium. Am J Hum Genet 1994; 54: 705-714.
  • 31
    Abecasis GR, Cookson WO. GOLD—graphical overview of linkage disequilibrium. Bioinformatics 2000; 16: 182-183.
  • 32
    Dietter J, Mattheisen M, Furst R, Ruschendorf F, Wienker TF, Strauch K. Linkage analysis using sex-specific recombination fractions with GENEHUNTER-MODSCORE. Bioinformatics 2007; 23: 64-70.
  • 33
    Lu K, Lee MH, Hazard S, Brooks-Wilson A, Hidaka H, Kojima H, et al. Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively. Am J Hum Genet 2001; 69: 278-290.
  • 34
    Hubacek JA, Berge KE, Cohen JC, Hobbs HH. Mutations in ATP-cassette binding proteins G5 (ABCG5) and G8 (ABCG8) causing sitosterolemia. Hum Mutat 2001; 18: 359-360.
    Direct Link:
  • 35
    Lammert F, Wasmuth HE, Méndez-Sánchez N, Rahbar-Tabrizi N, Schirin-Sokhan R, King-Martínez AC, et al. Common haplotypes of the ABCG5/G8 genes encoding the hepatocanalicular cholesterol transporter are associated with cholecystolithiasis. Eur J Clin Invest 2004; 34: 28-29.
  • 36
    Kong A, Cox NJ. Allele-sharing models: LOD scores and accurate linkage tests. Am J Hum Genet 1997; 61: 1179-1188.
  • 37
    Lindner TH, Hoffmann K. easyLINKAGE: a PERL script for easy and automated two-/multi-point linkage analyses. Bioinformatics 2005; 21: 405-407.
  • 38
    Cordell HJ. Bias toward the null hypothesis in model-free linkage analysis is highly dependent on the test statistic used. Am J Hum Genet 2004; 74: 1294-1302.
  • 39
    Abecasis GR, Wigginton JE. Handling marker-marker linkage disequilibrium: pedigree analysis with clustered markers. Am J Hum Genet 2005; 77: 754-767.
  • 40
    Puppala S, Dodd GD, Fowler S, Arya R, Schneider J, Farook VS, et al. A genomewide search finds major susceptibility loci for gallbladder disease on chromosome 1 in Mexican Americans. Am J Hum Genet 2006; 78: 377-392.
  • 41
    Schafmayer C, Tepel J, Franke A, Buch S, Lieb S, Seeger M, et al. Investigation of the Lith1 candidate genes ABCB11 and LXRA in human gallstone disease. HEPATOLOGY 2006; 44: 650-657.
  • 42
    Lammert F, Wang DQ, Hillebrandt S, Geier A, Fickert P, Trauner M, et al. Spontaneous cholecysto- and hepatolithiasis in Mdr2−/− mice: a model for low phospholipid-associated cholelithiasis. HEPATOLOGY 2004; 39: 117-128.
  • 43
    Buch S, Schafmayer C, Völzke H, Becker C, Franke A, von Eller-Eberstein H, et al. A genome-wide association scan identifies the hepatic cholesterol transporter ABCG5/ABCG8 as a susceptibility factor for human gallstone disease. Nat Genet 2007. In press.
  • 44
    Wang J, Sun F, Zhang DW, Ma Y, Xu F, Belani JD, et al. Sterol transfer by ABCG5 and ABCG8: in vitro assay and reconstitution. J Biol Chem 2006; 281: 27894-27904.
  • 45
    Gustafsson U, Sahlin S, Einarsson C. Biliary lipid composition in patients with cholesterol and pigment gallstones and gallstone-free subjects: deoxycholic acid does not contribute to formation of cholesterol gallstones. Eur J Clin Invest 2000; 30: 1099-1106.
  • 46
    Shaffer EA, Small DM. Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity. J Clin Invest 1977; 59: 828-840.
  • 47
    Angelin B, Backman L, Einarsson K, Eriksson L, Ewerth S. Hepatic cholesterol metabolism in obesity: activity of microsomal 3-hydroxy-3-methylglutaryl coenzyme A reductase. J Lipid Res 1982; 23: 770-773.
  • 48
    Smit JW, van Erpecum KJ, Stolk MF, Geerdink RA, Cluysenaer OJ, Erkelens DW, et al. Successful dissolution of cholesterol gallstone during treatment with pravastatin. Gastroenterology 1992; 103: 1068-1070.
  • 49
    Smit JW, van Erpecum KJ, Renooij W, Stolk MF, Edgar P, Doornewaard H, et al. The effects of the 3-hydroxy, 3-methylglutaryl coenzyme A reductase inhibitor pravastatin on bile composition and nucleation of cholesterol crystals in cholesterol gallstone disease. HEPATOLOGY 1995; 21: 1523-1529.
  • 50
    Lammert F, Wasmuth HE, Matern S. Molecular genetics of gallstone formation: human association studies and comparative genomics. In: AdlerG, BlumHE, FuchsM, StangeEF, eds. Gallstones: Pathogenesis and Treatment. Dordrecht: Kluwer Academic Publishers; 2004: 28-39.